Epileptiform discharge induced by 4-aminopyridine in magnesium-free medium in neocortical neurons: Physiological and pharmacological characterization

Neuroscience

Volumn 81, Issue 1, 1997, Pages 189-197

  Siniscalchi, A ^a,b   Calabresi, P ^b   Mercuri, N B ^a,b   Bernardi, G ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Epilepsy; Excitatory amino acids; GABA; Neocortex; Paroxysmal depolarization shift

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOPYRIDINE; EXCITATORY AMINO ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; DEPOLARIZATION; EPILEPTIC DISCHARGE; MALE; MEMBRANE POTENTIAL; NEOCORTEX; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

2-AMINO-5-PHOSPHONOVALERATE; 4-AMINOPYRIDINE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; CELLS, CULTURED; CULTURE MEDIA; DENDRITES; DOPAMINE; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MAGNESIUM; MALE; MEMBRANE POTENTIALS; NEOCORTEX; NEURONS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030855987     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00178-4     Document Type: Article

References (52)

1. 2+-induced epileptiform activity in rat cingulate cortex slice. NeuroReport. 5:1993;78-80.
2. Anderson W. W., Lewis D. V., Swartzweldert H. S., Wilson W. A. Magnesium-free medium activates seizure-like events in rat hippocampal slices. Brain Res. 398:1986;215-219.
3. 2+) in the human epileptogenic neocortex maintained in vitro. Brain Res. 417:1987;199-203.
4. A-mediated inhibition and in vitro epileptogenesis in the human neocortex. J. Neurophysiol. 73:1995;468-484.
5. Barkai E., Friedman A., Grossman Y., Gutnick M. J. Laminar pattern of synaptic inhibition during convulsive activity induced by 4-aminopyridine in neocortical slices. J. Neurophysiol. 73:1995;1462-1467.
6. Ben-Ari Y., Krnjevic K., Reinhardt W. Hippocampal seizures and failure of inhibition. Can. J. Physiol. Pharmac. 57:1979;1462-1466.
7. Bradford H. F. Glutamate, GABA and epilepsy. Prog. Neurobiol. 47:1995;477-511.
8. Buckle P. J., Haas H. L. Enhancement of synaptic transmission by 4-aminopyridine in hippocampal slices of the rat. J. Physiol., Lond. 326:1982;109-122.
9. Burke J. P., Hablitz J. J. Modulation of epileptiform activity by metabotropic glutamate receptors in immature rat neocortex. J. Neurophysiol. 73:1995;205-217.
10. Calabresi P., De Murtas M., Stefani A., Pisani A., Sancesario G., Mercuri N. B., Bernardi G. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission. Epilepsia. 36:1995;990-996.
11. Calabresi P., Siniscalchi A., Pisani A., Stefani A., Mercuri N. B., Bernardi G. A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices. Neurology. 47:1996;557-562.
12. Coan E. J., Collingridge G. L. Magnesium ions block an N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci. Lett. 53:1985;21-26.
13. Connors B. W., Guitnick M. J., Prince D. A. Electrophysiological properties of neocortical neurons in vitro. J. Neurophysiol. 48:1982;1302-1320.
14. Delgado-Escueta A. V., Ward A. A., Woodbury D. M. and Porter R. J. (1986) Advances in Neurology, Vol. 44. Raven Press, New York.
15. Dichter M. A., Ayala G. F. Cellular mechanisms of epilepsy: a status report. Science. 337:1987;157-164.
16. Goldamann-Rakic P. S., Leranth C., Williams S. M., Mons N., Geffard M. Dopamine synaptic complex with pyramidal neurones in primate cerebral cortex. Proc. natn. Acad. Sci. U.S.A. 86:1989;9015-9019.
17. Guitnick M. J., Connors B. W., Prince D. A. Mechanisms of neocortical epileptogenesis in vitro. J. Neurophysiol. 48:1982;1321-1335.
18. Haas H. L., Jefferys J. G. R., Slater N. T., Carpenter D. O. Modulation of low calcium-induced field burst in the hippocampus by monoamines and cholinomimetics. Pflügers Arch. 400:1984;28-33.
19. Hablitz J. J. Picrotoxin-induced epileptiform activity in hippocampus: role of endogenous versus synaptic factors. J. Neurophysiol. 51:1984;1011-1027.
20. Herron C. E., Lester R. A. J., Coan E. J., Collingridge G. L. Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature. 322:1986;265-268.
21. Hwa G. G. C., Avoli M. Excitatory synaptic transmission mediated by NMDA and non-NMDA receptors in the superficial/middle layers of the epileptogenic human neocortex maintained in vitro. Neurosci. Lett. 143:1992;83-86.
22. A-mediated postsynaptic inhibition in the rat hippocampus. J. Neurophysiol. 69:1993;764-771.
23. Johnston D., Brown T. H. Giant synaptic potential hypothesis for epileptiform activity. Science. 211:1981;294-297.
24. Lee W. L., Hablitz J. J. Initiation of epileptiform activity by excitatory amino acid receptors in the disinhibited rat neocortex. J. Neurophysiol. 65:1991;87-95.
25. MacDonald J. F., Porietis A. V., Wojtowicz J. M. L-Aspartic acid induces a region of negative slope conductance in the current-voltage relationship of cultured spinal cord neurons. Brain Res. 237:1982;248-253.
26. Matsumoto H., Ajmone-Marsan O. Cortical cellular phenomena in experimental epilepsy. II. Ictal manifestations. Expl Neurol. 9:1964;305-318.
27. 2+ on NMDA responses in spinal cord neuron. Nature. 309:1984;261-263.
28. McCormick D. A., Connors B. W., Lightall J. W., Prince D. A. Comparative electrophysiology of pyramidal sparsely spiny stellate neurons of the neocortex. J. Neurophysiol. 54:1985;782-806.
29. McNamara J. O. Cellular and molecular basis of epilepsy. J. Neurosci. 14:1994;3413-3425.
30. Miles R., Wong R. K. S. Inhibitory control of local excitatory circuits in the guinea-pig hippocampus. J. Physiol., Lond. 388:1987;611-629.
31. Neuman R. S., Cherubini E., Ben-Ari Y. Epileptiform bursts elicited in CA3 hippocampal neurons by a variety of convulsants are not blocked by N-methyl-D-aspartate antagonists. Brain Res. 459:1988;265-279.
32. Nowak L., Bregestovski P., Ascher P., Hebert A. Magnesium gates glutamate-activated channels in mouse central neurons. Nature. 307:1984;462-463.
33. Pisani A., Stefani A., Siniscalchi A., Mercuri N. B., Bernardi G., Calabresi P. Electrophysiological actions of felbamate on rat striatal neurones. Br. J. Pharmac. 116:1995;2053-2061.
34. Pralong E., Jones R. S. G. Interactions of dopamine with glutamate and GABA-mediated synaptic transmission in the rat entorhinal cortex in vitro. Eur. J. Neurosci. 5(6):1993;760-767.
35. Prince D. A., Connors B. W. Mechanisms of epileptogenesis in cortical structures. Ann. Neurol. 16:1984;S59-S64.
36. Rho J. M., Donevan S. D., Rogawski M. A. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acid A receptors. Ann. Neurol. 35:1994;229-234.
37. Rutecki P. A., Lebeda F. J., Johnston D. 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. J. Neurophysiol. 57:1987;1911-1924.
38. Schwartzkroin P. A., Prince D. A. Penicilline-induced epileptiform activity in the hippocampal in vitro preparation. Ann. Neurol. 1:1977;463-469.
39. Schwartzkroin P. A., Haglund M. M. Spontaneous rhythmic synchronous activity in epileptic human and normal monkey temporal lobe. Epilepsia. 27:1986;523-533.
40. B receptors of spontaneous synchronous activities induced by 4-aminopyridine in rat hippocampus. Neurosci. Lett. 148:1992;159-163.
41. Sombati S., Delorenzo R. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J. Neurophysiol. 73:1995;1706-1711.
42. Starr M. S. The role of dopamine in epilepsy. Synapse. 22:1996;159-194.
43. Sutor B., Zieglgansberger W. A low-voltage activated, transient current is responsible for the time-dependent depolarizing inward rectification of rat neocortical neurons in vitro. Pflügers Arch. 410:1987;102-111.
44. Thesleff S. Aminopyridines and synaptic transmission. Neuroscience. 5:1980;1413-1419.
45. Thomson A. M., West D. C. N-Methylaspartate receptors mediate epileptiform activity evoked in some, but not all, conditions in rat neocortical slices. Neuroscience. 19:1986;1161-1177.
46. Traub R. D., Colling S. B., Jefferys J. G. R. Cellular mechanisms of 4-aminopyridine-induced synchronized after-discharges in the rat hippocampal slices. J. Physiol. 486:1995;723-734.
47. Ulbricht W., Wagner H. H. Block of potassium channels of the nodal membrane by 4-aminopyridine and its removal by depolarization. Pflügers Arch. 3267:1976;77-87.
48. Valenzuela V., Benardo L. S. An in vitro model of persistent epileptiform activity in neocortex. Epilepsy Res. 21:1995;195-204.
49. Waldmeir P. C., Baumann P. A., Wicki P., Feldtrauer J. J., Stierlin C., Schmutz M. Similar potency of carbamazepine, oxcarbazepine and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology. 45:1995;1907-1913.
50. Whittington M. A., Traub R. D., Jefferys J. G. R. Erosion of inhibition contributes to the progression of low magnesium bursts in rat hippocampal slices. J. Physiol. 486:1995;723-734.
51. Yamaguchi S., Rogawski M. A. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res. 11:1992;9-16.
52. Zhang L. Z., Dreier G. P., Heinemann U. Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res. 20:1995;105-111.